Detalles de la búsqueda
1.
Lecanemab in Early Alzheimer's Disease.
N Engl J Med
; 388(1): 9-21, 2023 01 05.
Artículo
Inglés
| MEDLINE | ID: mdl-36449413
2.
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease.
Ann Neurol
; 95(2): 288-298, 2024 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-37830926
3.
Predicting clinical progression trajectories of early Alzheimer's disease patients.
Alzheimers Dement
; 20(3): 1725-1738, 2024 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-38087949
4.
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.
Alzheimers Dement
; 2024 Apr 17.
Artículo
Inglés
| MEDLINE | ID: mdl-38629508
5.
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
Alzheimers Dement
; 19(4): 1227-1233, 2023 04.
Artículo
Inglés
| MEDLINE | ID: mdl-35971310
6.
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
N Engl J Med
; 379(12): 1107-1117, 2018 09 20.
Artículo
Inglés
| MEDLINE | ID: mdl-30145941
7.
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
Lancet
; 392(10161): 2269-2279, 2018 11 24.
Artículo
Inglés
| MEDLINE | ID: mdl-30293771
8.
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials.
J Neurol Neurosurg Psychiatry
; 87(9): 993-9, 2016 09.
Artículo
Inglés
| MEDLINE | ID: mdl-27010616
9.
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.
Alzheimers Res Ther
; 16(1): 105, 2024 May 10.
Artículo
Inglés
| MEDLINE | ID: mdl-38730496
10.
ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study.
J Infect Dis
; 205(7): 1100-10, 2012 Apr 01.
Artículo
Inglés
| MEDLINE | ID: mdl-22351940
11.
Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial.
JAMA Netw Open
; 6(4): e237230, 2023 04 03.
Artículo
Inglés
| MEDLINE | ID: mdl-37040116
12.
ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease.
Alzheimers Dement (N Y)
; 9(1): e12377, 2023.
Artículo
Inglés
| MEDLINE | ID: mdl-36949897
13.
Decision making in clinical trials: Interim analyses, innovative design, and biomarkers.
Alzheimers Dement (N Y)
; 9(4): e12421, 2023.
Artículo
Inglés
| MEDLINE | ID: mdl-37867532
14.
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease.
Alzheimers Res Ther
; 14(1): 182, 2022 12 09.
Artículo
Inglés
| MEDLINE | ID: mdl-36482412
15.
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.
Alzheimers Res Ther
; 14(1): 191, 2022 12 21.
Artículo
Inglés
| MEDLINE | ID: mdl-36544184
16.
Fully automated and highly specific plasma ß-amyloid immunoassays predict ß-amyloid status defined by amyloid positron emission tomography with high accuracy.
Alzheimers Res Ther
; 14(1): 86, 2022 06 23.
Artículo
Inglés
| MEDLINE | ID: mdl-35739591
17.
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aß protofibril antibody.
Alzheimers Res Ther
; 13(1): 80, 2021 04 17.
Artículo
Inglés
| MEDLINE | ID: mdl-33865446
18.
Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303.
Eur J Paediatr Neurol
; 23(1): 126-135, 2019 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-30309816
19.
Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
JAMA Netw Open
; 2(12): e1918254, 2019 12 02.
Artículo
Inglés
| MEDLINE | ID: mdl-31880796
20.
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
Transplantation
; 83(12): 1639-42, 2007 Jun 27.
Artículo
Inglés
| MEDLINE | ID: mdl-17589349